Albelda SM - Search Results

1

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.

Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A. Zhuang H, et al. Among authors: albelda sm. J Nucl Med. 2001 Sep;42(9):1412-7. J Nucl Med. 2001. PMID: 11535734 Free article.

2

Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.

Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Bénard F, et al. Among authors: albelda sm. Chest. 1998 Sep;114(3):713-22. doi: 10.1378/chest.114.3.713. Chest. 1998. PMID: 9743156 Free article.

3

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

Molnar-Kimber KL, Sterman DH, Chang M, Kang EH, ElBash M, Lanuti M, Elshami A, Gelfand K, Wilson JM, Kaiser LR, Albelda SM. Molnar-Kimber KL, et al. Among authors: albelda sm. Hum Gene Ther. 1998 Sep 20;9(14):2121-33. doi: 10.1089/hum.1998.9.14-2121. Hum Gene Ther. 1998. PMID: 9759938 Clinical Trial.

4

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.

Lanuti M, Gao GP, Force SD, Chang MY, El Kouri C, Amin KM, Hughes JV, Wilson JM, Kaiser LR, Albelda SM. Lanuti M, et al. Among authors: albelda sm. Hum Gene Ther. 1999 Feb 10;10(3):463-75. doi: 10.1089/10430349950018904. Hum Gene Ther. 1999. PMID: 10048398

5

Prognostic value of FDG PET imaging in malignant pleural mesothelioma.

Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Bénard F, et al. Among authors: albelda sm. J Nucl Med. 1999 Aug;40(8):1241-5. J Nucl Med. 1999. PMID: 10450672 Free article.

6

Use of protamine to augment adenovirus-mediated cancer gene therapy.

Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S. Lanuti M, et al. Gene Ther. 1999 Sep;6(9):1600-10. doi: 10.1038/sj.gt.3300987. Gene Ther. 1999. PMID: 10490770

7

A rapid and sensitive method for the quantification of ganciclovir in plasma using liquid chromatography/selected reaction monitoring/mass spectrometry.

Xu K, Lanuti M, Lambright ES, Force SD, Albelda SM, Blair IA. Xu K, et al. Among authors: albelda sm. Biomed Chromatogr. 2000 Apr;14(2):93-8. doi: 10.1002/(SICI)1099-0801(200004)14:2<93::AID-BMC932>3.0.CO;2-0. Biomed Chromatogr. 2000. PMID: 10694702

8

Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.

Lanuti M, Rudginsky S, Force SD, Lambright ES, Siders WM, Chang MY, Amin KM, Kaiser LR, Scheule RK, Albelda SM. Lanuti M, et al. Among authors: albelda sm. Cancer Res. 2000 Jun 1;60(11):2955-63. Cancer Res. 2000. PMID: 10850443

9

Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model.

Lambright ES, Kang EH, Force S, Lanuti M, Caparrelli D, Kaiser LR, Albelda SM, Molnar-Kimber KL. Lambright ES, et al. Among authors: albelda sm. Mol Ther. 2000 Oct;2(4):387-93. doi: 10.1006/mthe.2000.0133. Mol Ther. 2000. PMID: 11020355 Free article.

10

Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model.

Lambright ES, Force SD, Lanuti ME, Wasfi DS, Amin KM, Albelda SM, Kaiser LR. Lambright ES, et al. Among authors: albelda sm. Ann Thorac Surg. 2000 Dec;70(6):1865-70; discussion 1870-1. doi: 10.1016/s0003-4975(00)01815-4. Ann Thorac Surg. 2000. PMID: 11156085 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters